News

Published on 13 Dec 2024 on Benzinga

What's Going On With Candel Therapeutics Shares Friday? - Candel Therapeutics...

Article preview image

Candel Therapeutics, Inc. CADL shares are moving lower on Friday after the company priced its $80 million underwritten public offering of shares and pre-funded warrants.

The Details: The offering is priced at $6.00 per share for approximately 10 million shares. The company has also provided the underwriters with a 30-day option to buy up to 2 million additional common shares at the public offering price, minus the underwriting discount.

Read the rest of the article
NASDAQ.CADL price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Insider Stock Buying Of Candel Therapeutics Delivers Return On US$3.00m...

Candel Therapeutics, Inc. (NASDAQ:CADL) insiders who acquired shares over the previous 12 months,...

Simply Wall St. · via Yahoo Finance 18 Jan 2025
Candel Therapeutics raises $92M in public offering following prostate cancer...

Candel Therapeutics Inc (NASDAQ:CADL) announced on Monday the completion of a public offering tha...

Proactive Investors 17 Dec 2024
Candel Therapeutics stock drops after pricing public offering By Investing.com

Shares of Candel Therapeutics, Inc. (NASDAQ:CADL) saw a 30% decrease in premarket trading today...

Investing.com 13 Dec 2024
Candel Therapeutics unveils $80M public offering

Candel Therapeutics Inc (NASDAQ:CADL) has announced an $80 million underwritten public offering o...

Proactive Investors 13 Dec 2024
What's Going On With Candel Therapeutics Shares Friday? - Candel Therapeutics...

Candel Therapeutics, Inc. CADL shares are moving lower on Friday after the company priced its $80...

Benzinga 13 Dec 2024
CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary Goal

Candel stock rallies 68% on meeting the primary goal in a phase III study of CAN-2409 combo thera...

Zacks · via Yahoo Finance 12 Dec 2024
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.22% By...

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.22%

Investing.com 12 Dec 2024
Candel Therapeutics Stock Surges Over 100% - Here's Why

On Wednesday, Candel Therapeutics, Inc. (NASDAQ:CADL) announced results from a phase 3 trial of...

Benzinga · via Yahoo Finance 11 Dec 2024
Candel Therapeutics Prostate Cancer Therapy Shows Promise

By Karen Roman Candel Therapeutics, Inc. (Nasdaq: CADL) said Phase 3 of its prostate cancer...

Exec Edge · via Yahoo Finance 11 Dec 2024
Crude Oil Jumps 2%; Macy's Lowers Earnings Forecast - Candel Therapeutics...

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 300...

Benzinga 11 Dec 2024

Copyright Statfolio @ 2025

Social Accounts